Aktana
San Francisco, US · Delaware corporation · 209 employees on LinkedIn · 6 known investors
Find your way into Aktana
211 people in our graph share verified history with the Aktana team — schools, employers, funds. One of them is your warm intro.
Aktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times. The system delivers healthcare professional-level impact tracking and enables rapid campaign deployment for pharma companies and their marketing teams.
Founders & leadership

Board
Investors · 6
Reported raises · per SEC filings
Form D private placements$75.3M disclosed across 4 rounds · 2016–2020
▶$14.6MraisedOct 2020 · 13 investors · Other TechnologyRule 506(b)
- Doug DennerlineDirector
- Robert MittendorffDirector
- David J. EhrlichExecutive Officer, Director
- John DysonDirector
- Derek ChoyExecutive Officer, Director
- Gary KurtzmanDirector
- Jared KesselheimDirector
- Colm CallanExecutive Officer
- Offering amount
- $14.6M
- Amount sold
- $14.6M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedOct 2020 · 8 investors · Other TechnologyRule 506(b)
- Robert MittendorffDirector
- David J. EhrlichExecutive Officer, Director
- John DysonDirector
- Derek ChoyExecutive Officer, Director
- Doug DennerlineDirector
- Jared KesselheimDirector
- Gary KurtzmanDirector
- Colm CallanExecutive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.1MraisedOct 2018 · 9 investors · Other TechnologyRule 506(b)
- John DysonDirector
- Jared KesselheimDirector
- David J. EhrlichExecutive Officer, Director
- Richard Van HoesenExecutive Officer
- Gary KurtzmannDirector
- Derek ChoyExecutive Officer, Director
- Offering amount
- $21.1M
- Amount sold
- $21.1M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.6MraisedJun 2016 · 11 investors · Other TechnologyRule 506(b)
- Anthony GlenningDirector
- Jin HuangExecutive Officer
- Al WiegmanDirector
- Rob WillsonExecutive Officer
- Eric GilbertDirector
- Marc-david CohenExecutive Officer
- David J. EhrlichExecutive Officer, Director
- Derek ChoyExecutive Officer, Director
- Offering amount
- $17.6M
- Amount sold
- $9.6M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapCompanies competing with Aktana for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 1
Early investors' stakes continue via these dealsIn the news
Frequently asked questions
- What does Aktana do?
- Aktana provides a real-time orchestration platform for pharmaceutical marketing that coordinates digital and field engagement across channels to reach healthcare professionals at optimal times. The system delivers healthcare professional-level impact tracking and enables rapid campaign deployment for pharma companies and their marketing teams.
- Who founded Aktana?
- Aktana was founded by David J. Ehrlich, Derek Choy.
- Who are Aktana's investors?
- Aktana's investors include HLM Venture Partners, Norwest Venture Partners, Starfish Ventures, TRANSFORMATION CAPITAL, Upfront Ventures, B4 Capital.
- How much funding has Aktana raised?
- Aktana has disclosed $75.3M raised across 4 rounds.
- Where is Aktana headquartered?
- Aktana is headquartered in San Francisco, US.





